Shenzhen - Delayed Quote CNY
Pharmaron Beijing Co., Ltd. (300759.SZ)
24.84
-0.63
(-2.47%)
At close: 3:04:16 PM GMT+8
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
23,927,398.32
26,476,712.84
20,492,557.23
18,389,124.35
Total Liabilities Net Minority Interest
9,704,526.04
13,238,666.50
9,652,689.51
8,093,817.61
Total Equity Gross Minority Interest
14,222,872.28
13,238,046.34
10,839,867.72
10,295,306.74
Total Capitalization
17,996,701.79
20,756,462.47
15,002,876.38
14,552,425.99
Common Stock Equity
13,619,333.91
12,556,797.36
10,548,615.36
10,129,240.93
Capital Lease Obligations
401,307.32
585,197.42
760,514.56
284,337.63
Net Tangible Assets
10,067,596.15
8,986,822.96
7,058,215.98
7,340,040.59
Working Capital
3,384,174.25
7,219,937.35
2,623,573.94
5,661,505.50
Invested Capital
18,761,671.83
21,333,533.68
15,665,643.77
14,974,182.51
Tangible Book Value
10,067,596.15
8,986,822.96
7,058,215.98
7,340,040.59
Total Debt
5,975,492.47
9,697,590.58
6,116,522.23
5,285,116.05
Net Debt
3,452,421.84
2,857,821.04
3,619,544.58
1,301,121.87
Share Issued
1,777,786.01
1,786,732.21
1,786,601.44
1,786,898.47
Ordinary Shares Number
1,777,786.01
1,786,732.21
1,786,601.44
1,786,898.47
12/31/2021 - 1/28/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GXE.F Galapagos NV
24.40
-1.37%
BT3.BE Lineage Cell Therapeutics Inc
0.5850
-0.85%
ITRX inTerra Resources Corp
0.0240
0.00%
8QQ.BE AbCellera Biologics Inc
2.5800
-6.99%
GENSY Genus plc
24.34
0.00%
ONCIN.OL Oncoinvent ASA
1.8500
-8.64%
AB3A.MU Sarepta Therapeutics Inc
31.60
-1.86%
AYJ.HA Valneva SE
2.6880
-1.54%
688180.SS Shanghai Junshi Biosciences Co., Ltd.
36.08
-6.65%
ERGO Entia Biosciences, Inc.
0.0001
0.00%